METHYLERGONOVINE

METHYLERGONOVINE was reported 610 times

METHYLERGONOVINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PELVIC FIBROSIS 1 0.1667
1 SIRENOMELIA 1 0.0278
2 BANDAEMIA 3 0.0204
3 BASE EXCESS 1 0.0192
4 MYOCARDIAL STUNNING 2 0.0149
5 CYTOTOXIC LESIONS OF CORPUS CALLOSUM 2 0.0135
6 NEONATAL RESPIRATORY ACIDOSIS 2 0.0132
7 ELECTROCARDIOGRAM Q WAVE ABNORMAL 3 0.0128
8 EXAGGERATED STARTLE RESPONSE 2 0.0109
9 ANAPHYLACTOID SYNDROME OF PREGNANCY 1 0.0104
10 POSTPARTUM DISORDER 1 0.0093
11 ERGOT POISONING 1 0.0080
12 POST ABORTION HAEMORRHAGE 1 0.0070
13 BLOOD LACTIC ACID DECREASED 1 0.0058
14 NSAID EXACERBATED RESPIRATORY DISEASE 2 0.0053
15 GENERAL PHYSICAL CONDITION DECREASED 1 0.0053
16 PLACENTA ACCRETA 1 0.0046
17 DRUG LABEL CONFUSION 1 0.0040
18 APNOEA NEONATAL 1 0.0039
19 POSTURING 2 0.0038
20 CYANOSIS CENTRAL 1 0.0038
21 UTERINE ATONY 1 0.0038
22 CSF PRESSURE INCREASED 1 0.0038
23 ANGIOGRAM 1 0.0036
24 PRODUCT APPEARANCE CONFUSION 3 0.0032
25 CYANOSIS NEONATAL 2 0.0031
26 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL 1 0.0031
27 NEONATAL RESPIRATORY DEPRESSION 1 0.0030
28 CEREBRAL VASOCONSTRICTION 2 0.0027
29 ABSCESS RUPTURE 1 0.0027
30 CAPILLARY DISORDER 1 0.0026
31 MITRAL VALVE REPLACEMENT 1 0.0025
32 ELECTROCARDIOGRAM T WAVE INVERSION 5 0.0023
33 VASCULITIS CEREBRAL 1 0.0022
34 LOCKED-IN SYNDROME 1 0.0022
35 TACHYCARDIA FOETAL 1 0.0020
36 ARTERIOSPASM CORONARY 8 0.0020
37 ALBUMINURIA 1 0.0019
38 PRODUCT NAME CONFUSION 2 0.0018
39 BRADYCARDIA NEONATAL 2 0.0016
40 ENDOMETRITIS 1 0.0015
41 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
42 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1 0.0015
43 NEONATAL ASPHYXIA 1 0.0014
44 AMNIOTIC CAVITY INFECTION 1 0.0014
45 HEART SOUNDS ABNORMAL 1 0.0013
46 HYPERCAPNIA 4 0.0013
47 BLOOD FIBRINOGEN INCREASED 1 0.0013
48 OPISTHOTONUS 1 0.0013
49 ACUTE PULMONARY OEDEMA 7 0.0012
50 SEPSIS NEONATAL 1 0.0012
51 INFANTILE APNOEA 1 0.0012
52 VASOCONSTRICTION 1 0.0011
53 VASOSPASM 1 0.0011
54 ABDOMINAL WALL HAEMATOMA 2 0.0010
55 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 2 0.0010
56 MATERNAL EXPOSURE DURING DELIVERY 1 0.0010
57 PRODUCT BLISTER PACKAGING ISSUE 1 0.0010
58 LIVEDO RETICULARIS 2 0.0010
59 FEEDING DISORDER NEONATAL 1 0.0010
60 INFUSION SITE MASS 1 0.0009
61 PRODUCT SELECTION ERROR 1 0.0009
62 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 2 0.0009
63 MYOCARDIAL INJURY 1 0.0009
64 KOUNIS SYNDROME 2 0.0009
65 PRODUCT PACKAGING CONFUSION 2 0.0008
66 OLIGURIA 5 0.0008
67 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
68 TROPONIN T INCREASED 1 0.0008
69 WRONG DRUG ADMINISTERED 7 0.0008
70 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
71 TONIC CLONIC MOVEMENTS 1 0.0008
72 CLUSTER HEADACHE 1 0.0007
73 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
74 HYPERTHERMIA MALIGNANT 1 0.0007
75 INFERTILITY 1 0.0007
76 TRANSCRIPTION MEDICATION ERROR 1 0.0006
77 STUPOR 2 0.0006
78 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
79 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
80 GAZE PALSY 1 0.0006
81 BLOOD PH DECREASED 1 0.0006
82 INCORRECT STORAGE OF DRUG 1 0.0006
83 INFUSION SITE DISCHARGE 1 0.0006
84 INTERCEPTED PRODUCT STORAGE ERROR 2 0.0006
85 OESOPHAGEAL SPASM 1 0.0005
86 JAUNDICE NEONATAL 1 0.0005
87 BLOOD BICARBONATE DECREASED 1 0.0005
88 TROPONIN INCREASED 4 0.0005
89 APNOEA 4 0.0005
90 CORONARY ARTERY THROMBOSIS 1 0.0005
91 UTERINE HAEMORRHAGE 2 0.0005
92 OCULOGYRIC CRISIS 1 0.0005
93 HAEMATOCRIT INCREASED 1 0.0004
94 ISCHAEMIA 2 0.0004
95 EYE OEDEMA 1 0.0004
96 HYPERLACTACIDAEMIA 1 0.0004
97 NORMAL NEWBORN 2 0.0004
98 LIVE BIRTH 3 0.0004
99 HYPERTONIA 2 0.0003
100 ABORTION 1 0.0003
101 CEREBROVASCULAR DISORDER 1 0.0003
102 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
103 RESPIRATORY DEPRESSION 4 0.0003
104 INTRACARDIAC THROMBUS 1 0.0003
105 BLOOD CREATININE DECREASED 1 0.0003
106 CYANOSIS 5 0.0003
107 VENTRICULAR HYPOKINESIA 1 0.0003
108 EXPOSURE DURING BREAST FEEDING 1 0.0003
109 WRONG PRODUCT ADMINISTERED 2 0.0003
110 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
111 HYPOPNOEA 1 0.0003
112 MITRAL VALVE INCOMPETENCE 3 0.0003
113 CLAVICLE FRACTURE 1 0.0003
114 EPIGASTRIC DISCOMFORT 1 0.0003
115 RESPIRATORY ACIDOSIS 1 0.0003
116 PATENT DUCTUS ARTERIOSUS 1 0.0003
117 EXPOSURE VIA BREAST MILK 1 0.0003
118 AZOTAEMIA 1 0.0003
119 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
120 DYSPHEMIA 1 0.0002
121 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
122 TIBIA FRACTURE 1 0.0002
123 PRE-ECLAMPSIA 1 0.0002
124 GESTATIONAL DIABETES 1 0.0002
125 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
126 ACUTE RESPIRATORY FAILURE 4 0.0002
127 SINUS BRADYCARDIA 2 0.0002
128 VENTRICULAR EXTRASYSTOLES 2 0.0002
129 PRODUCT DISPENSING ERROR 4 0.0002
130 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
131 INTERMENSTRUAL BLEEDING 1 0.0002
132 NEUROLOGICAL SYMPTOM 1 0.0002
133 CORONARY ARTERY BYPASS 1 0.0002
134 MUSCLE RIGIDITY 2 0.0002
135 PRE-EXISTING CONDITION IMPROVED 1 0.0002
136 INFUSION SITE SWELLING 1 0.0002
137 MYDRIASIS 2 0.0002
138 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
139 LYMPHOEDEMA 1 0.0001
140 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
141 PRODUCT SUPPLY ISSUE 1 0.0001
142 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
143 VISUAL FIELD DEFECT 1 0.0001
144 HAEMODYNAMIC INSTABILITY 1 0.0001
145 ACIDOSIS 1 0.0001
146 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
147 HAEMOLYSIS 1 0.0001
148 MULTIPLE ALLERGIES 1 0.0001
149 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
150 RENAL CYST 1 0.0001
151 LOW BIRTH WEIGHT BABY 1 0.0001
152 ATRIAL FLUTTER 1 0.0001
153 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
154 UNRESPONSIVE TO STIMULI 3 0.0001
155 CARDIAC MURMUR 1 0.0001
156 LUNG INFILTRATION 1 0.0001
157 RESPIRATORY RATE INCREASED 1 0.0001
158 PELVIC PAIN 2 0.0001
159 CRYING 4 0.0001
160 GRAND MAL CONVULSION 1 0.0001
161 FOOT FRACTURE 2 0.0001
162 ATELECTASIS 1 0.0001
163 SUBARACHNOID HAEMORRHAGE 1 0.0001
164 METABOLIC ACIDOSIS 3 0.0001
165 PULMONARY THROMBOSIS 1 0.0001
166 STATUS EPILEPTICUS 1 0.0001
167 HYPOXIA 3 0.0001
168 CARDIAC ARREST 7 0.0001
169 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
170 EXPOSURE DURING PREGNANCY 5 0.0001
171 TOOTH EXTRACTION 1 0.0001
172 POISONING 1 0.0001
173 BRAIN OEDEMA 1 0.0001
174 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
175 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
176 INFUSION SITE PAIN 1 0.0001
177 IMMUNE SYSTEM DISORDER 1 0.0001
178 EYE HAEMORRHAGE 1 0.0001
179 PRODUCT TASTE ABNORMAL 1 0.0001
180 PALLOR 2 0.0001
181 CORONARY ARTERY OCCLUSION 1 0.0001
182 RESPIRATORY ARREST 2 0.0001
183 RESPIRATORY DISTRESS 2 0.0001
184 MENTAL STATUS CHANGES 2 0.0001
185 COMPLETED SUICIDE 6 0.0001
186 CARDIOGENIC SHOCK 1 0.0001
187 PREMATURE BABY 2 0.0001
188 BLOOD COUNT ABNORMAL 1 0.0001
189 EJECTION FRACTION DECREASED 1 0.0001
190 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
191 PREMATURE DELIVERY 1 0.0001
192 MUSCLE TIGHTNESS 1 0.0001
193 BACK DISORDER 1 0.0001
194 VENTRICULAR TACHYCARDIA 1 0.0001
195 MUSCULOSKELETAL DISCOMFORT 1 0.0001
196 ORTHOSTATIC HYPOTENSION 1 0.0001
197 SYRINGE ISSUE 1 0.0001
198 LEUKOCYTOSIS 1 0.0001
199 HYPONATRAEMIA 3 0.0001
200 FRACTURE 1 0.0001
201 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
202 LOWER LIMB FRACTURE 1 0.0001
203 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
204 KIDNEY INFECTION 1 0.0001
205 IRRITABILITY 3 0.0000
206 DYSKINESIA 2 0.0000
207 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
208 PRODUCT PRESCRIBING ISSUE 1 0.0000
209 BLOOD PRESSURE DECREASED 3 0.0000
210 TACHYCARDIA 4 0.0000
211 SHOCK 1 0.0000
212 PERICARDIAL EFFUSION 1 0.0000
213 CHEST PAIN 8 0.0000
214 LOCALISED INFECTION 1 0.0000
215 NEURALGIA 1 0.0000
216 ENCEPHALOPATHY 1 0.0000
217 DRY EYE 2 0.0000
218 CARDIOVASCULAR DISORDER 1 0.0000
219 DIPLOPIA 1 0.0000
220 RESPIRATORY TRACT INFECTION 1 0.0000
221 SEDATION 1 0.0000
222 SPEECH DISORDER 2 0.0000
223 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
224 EAR INFECTION 1 0.0000
225 ARTHROPATHY 2 0.0000
226 MEDICATION ERROR 2 0.0000
227 OXYGEN SATURATION DECREASED 2 0.0000
228 SEIZURE 4 0.0000
229 ACUTE MYOCARDIAL INFARCTION 1 0.0000
230 APHASIA 1 0.0000
231 LACRIMATION INCREASED 1 0.0000
232 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
233 PLEURAL EFFUSION 2 0.0000
234 EMOTIONAL DISORDER 1 0.0000
235 CYSTITIS 1 0.0000
236 LACTIC ACIDOSIS 1 0.0000
237 STAPHYLOCOCCAL INFECTION 1 0.0000
238 VIRAL INFECTION 1 0.0000
239 FUNGAL INFECTION 1 0.0000
240 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
241 CHEST DISCOMFORT 3 0.0000
242 HAEMATURIA 1 0.0000
243 HAEMORRHAGE 3 0.0000
244 ACCIDENTAL OVERDOSE 1 0.0000
245 BRONCHITIS 2 0.0000
246 DYSARTHRIA 1 0.0000
247 BLOOD PRESSURE INCREASED 4 0.0000
248 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
249 ABORTION SPONTANEOUS 1 0.0000
250 HYPOTENSION 5 0.0000
251 DEVICE BREAKAGE 1 0.0000
252 CARDIO-RESPIRATORY ARREST 1 0.0000
253 ROAD TRAFFIC ACCIDENT 1 0.0000
254 TOXICITY TO VARIOUS AGENTS 4 0.0000
255 HYPERTENSION 5 0.0000
256 LOSS OF CONSCIOUSNESS 3 0.0000
257 MYOCARDIAL INFARCTION 4 0.0000
258 ANGIOEDEMA 1 0.0000
259 PULMONARY OEDEMA 1 0.0000
260 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
261 SKIN DISCOLOURATION 1 0.0000
262 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
263 SWELLING 2 0.0000
264 OCULAR HYPERAEMIA 1 0.0000
265 DISEASE RECURRENCE 1 0.0000
266 DRUG INTOLERANCE 2 0.0000
267 LUNG DISORDER 1 0.0000
268 AGGRESSION 1 0.0000
269 SINUSITIS 2 0.0000
270 DYSPNOEA 11 0.0000
271 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
272 ABDOMINAL DISTENSION 2 0.0000
273 NERVOUSNESS 1 0.0000
274 BRADYCARDIA 1 0.0000
275 TREATMENT NONCOMPLIANCE 1 0.0000
276 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
277 ANAPHYLACTIC REACTION 1 0.0000
278 TREMOR 3 0.0000
279 SEPSIS 2 0.0000
280 EYE PAIN 1 0.0000
281 ASTHMA 2 0.0000
282 MYALGIA 3 0.0000
283 CONVULSION 1 0.0000
284 LETHARGY 1 0.0000
285 EYE IRRITATION 1 0.0000
286 DYSPHONIA 1 0.0000
287 CHILLS 2 0.0000
288 SUICIDE ATTEMPT 1 0.0000
289 STOMATITIS 1 0.0000
290 OEDEMA PERIPHERAL 2 0.0000
291 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
292 BLOOD CREATININE INCREASED 1 0.0000
293 INFUSION RELATED REACTION 1 0.0000
294 VISION BLURRED 2 0.0000
295 DEVICE MALFUNCTION 1 0.0000
296 AGITATION 1 0.0000
297 HALLUCINATION 1 0.0000
298 UNEVALUABLE EVENT 1 0.0000
299 DECREASED APPETITE 3 0.0000
300 VOMITING 6 0.0000
301 INJECTION SITE BRUISING 1 0.0000
302 CARDIAC FAILURE 1 0.0000
303 DRUG INEFFECTIVE 16 0.0000
304 DRUG ABUSE 1 0.0000
305 ABDOMINAL DISCOMFORT 2 0.0000
306 PYREXIA 4 0.0000
307 NO ADVERSE EVENT 2 0.0000
308 SUICIDAL IDEATION 1 0.0000
309 NASOPHARYNGITIS 2 0.0000
310 OROPHARYNGEAL PAIN 1 0.0000
311 HYPERSENSITIVITY 2 0.0000
312 CARDIAC DISORDER 1 0.0000
313 PRODUCT USE ISSUE 2 0.0000
314 MIGRAINE 1 0.0000
315 ATRIAL FIBRILLATION 1 0.0000
316 HEART RATE INCREASED 1 0.0000
317 SYNCOPE 1 0.0000
318 CONDITION AGGRAVATED 3 0.0000
319 HAEMOGLOBIN DECREASED 1 0.0000
320 ILLNESS 1 0.0000
321 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
322 OFF LABEL USE 8 0.0000
323 INFLUENZA 1 0.0000
324 INJECTION SITE ERYTHEMA 1 0.0000
325 PRODUCT QUALITY ISSUE 1 0.0000
326 WEIGHT DECREASED 2 0.0000
327 ANXIETY 2 0.0000
328 INFECTION 1 0.0000
329 MALAISE 3 0.0000
330 PERIPHERAL SWELLING 1 0.0000
331 HEADACHE 4 0.0000
332 PARAESTHESIA 1 0.0000
333 NAUSEA 5 0.0000
334 CONFUSIONAL STATE 1 0.0000
335 DRUG DOSE OMISSION 1 0.0000
336 URINARY TRACT INFECTION 1 0.0000
337 COVID-19 1 0.0000
338 BLOOD GLUCOSE INCREASED 1 0.0000
339 PRURITUS 2 0.0000
340 SOMNOLENCE 1 0.0000
341 PAIN 3 0.0000
342 DIARRHOEA 3 0.0000
343 OVERDOSE 1 0.0000
344 RASH 2 0.0000
345 CONSTIPATION 1 0.0000
346 DEPRESSION 1 0.0000
347 BACK PAIN 1 0.0000
348 ABDOMINAL PAIN 1 0.0000
349 FEELING ABNORMAL 1 0.0000
350 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
351 DIZZINESS 2 0.0000
352 FATIGUE 3 0.0000
353 COUGH 1 0.0000
354 PRODUCT DOSE OMISSION ISSUE 1 0.0000
355 PAIN IN EXTREMITY 1 0.0000
356 PNEUMONIA 1 0.0000
357 FALL 1 0.0000
358 ARTHRALGIA 1 0.0000
359 DEATH 1 0.0000